Insider Transactions in Q1 2023 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.39%
|
$30,000
$15.07 P/Share
|
|
Mar 02
2023
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,028
-1.4%
|
$11,308
$11.6 P/Share
|
|
Mar 02
2023
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,324
-1.27%
|
$36,564
$11.6 P/Share
|
|
Mar 02
2023
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,058
-0.56%
|
$11,638
$11.6 P/Share
|
|
Mar 02
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,747
-2.0%
|
$17,470
$10.85 P/Share
|
|
Mar 02
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,005
-2.24%
|
$11,055
$11.6 P/Share
|
|
Mar 02
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,641
-1.92%
|
$16,410
$10.86 P/Share
|
|
Mar 02
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
945
-2.15%
|
$10,395
$11.6 P/Share
|
|
Mar 01
2023
|
Nathan J Dowden President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
28,400
+27.82%
|
-
|
|
Mar 01
2023
|
Dipal Doshi CEO |
BUY
Grant, award, or other acquisition
|
Direct |
99,300
+27.55%
|
-
|
|
Mar 01
2023
|
Natarajan Sethuraman President, Research & Develop. |
BUY
Grant, award, or other acquisition
|
Direct |
28,400
+12.97%
|
-
|
|
Mar 01
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,400
+38.74%
|
-
|
|
Mar 01
2023
|
Nerissa Kreher Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,400
+39.27%
|
-
|
|
Feb 28
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.22%
|
$24,000
$12.0 P/Share
|
|
Jan 27
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.21%
|
$24,000
$12.0 P/Share
|
|
Jan 09
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,410
-1.43%
|
$36,150
$15.02 P/Share
|